Literature DB >> 3493020

Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins.

W M Behan, P O Behan, J Gairns.   

Abstract

Cardiac damage, consisting of mild diffuse myocarditis or severe inflammation and fibrosis of the conduction system or both, occurs in more than 70% of patients with idiopathic polymyositis. The lesions are strikingly similar to those detected in the infants of mothers with connective tissue diseases. In these infants the damage is associated with the transplacental passage of a maternal antibody to tissue ribonucleoproteins (anti-Ro). The same antibody was identified in 60% of 55 patients with polymyositis and in 69% (23/33) of those with associated cardiac damage including four with complete heart block. Forty five per cent of those patients who were anti-Ro seropositive had no clinical or electrocardiographic evidence of cardiac lesions. They were in the acute phase of illness, however, and no other more detailed heart investigations had been done. It is postulated that cardiac damage in polymyositis is caused by the antibody and that its presence may serve as a marker for heart involvement.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493020      PMCID: PMC1277101          DOI: 10.1136/hrt.57.2.176

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  Congenital heart block. Anatomic correlations and review of the literature.

Authors:  J B Carter; L C Blieden; J E Edwards
Journal:  Arch Pathol       Date:  1974-01

2.  Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue.

Authors:  S E Litsey; J A Noonan; W N O'Connor; C M Cottrill; B Mitchell
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

3.  Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.

Authors:  R M Bernstein; S H Morgan; J Chapman; C C Bunn; M B Mathews; M Turner-Warwick; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-21

4.  Congenital complete heart block and connective-tissue disease.

Authors:  V L Vetter; W J Rashkind
Journal:  N Engl J Med       Date:  1983-07-28       Impact factor: 91.245

5.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

6.  Purification and characterization of the Sjögren's syndrome A and B antigens.

Authors:  P J Venables; P R Smith; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  New findings in neonatal lupus syndrome.

Authors:  L A Lee; W L Weston
Journal:  Am J Dis Child       Date:  1984-03

8.  Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block.

Authors:  J S Scott; P J Maddison; P V Taylor; E Esscher; O Scott; R P Skinner
Journal:  N Engl J Med       Date:  1983-07-28       Impact factor: 91.245

9.  ECG abnormalities in polymyositis.

Authors:  R Stern; J H Godbold; Q Chess; L J Kagen
Journal:  Arch Intern Med       Date:  1984-11

10.  The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs.

Authors:  S L Wolin; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more
  12 in total

Review 1.  Humoral immune response to cardiac conducting tissue.

Authors:  U Lotze; B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.

Authors:  D Logar; T Kveder; B Rozman; J Dobovisek
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

Review 3.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

4.  Family studies of congenital heart block associated with Ro antibody.

Authors:  W M Behan; P O Behan; J M Reid; W Doig; J Gairns
Journal:  Br Heart J       Date:  1989-10

5.  Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography.

Authors:  Angela Rosenbohm; Dominik Buckert; Nora Gerischer; Thomas Walcher; Jan Kassubek; Wolfgang Rottbauer; Albert C Ludolph; Peter Bernhardt
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

6.  Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients : A systematic review and meta-analysis.

Authors:  Hui Wang; Yuan Zhu; Jingjing Hu; Jieni Jin; Jun Lu; Cong Shen; Zhaobin Cai
Journal:  Z Rheumatol       Date:  2022-05-16       Impact factor: 1.372

7.  Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry.

Authors:  Lixi Zhang; Huiyi Zhu; Pinting Yang; Xinwang Duan; Wei Wei; Zhenbiao Wu; Yongfei Fang; Qin Li; Shengyun Liu; Xiaofei Shi; Hongbin Li; Chanyuan Wu; Shuang Zhou; Xiaomei Leng; Jiuliang Zhao; Dong Xu; Qingjun Wu; Xinping Tian; Mengtao Li; Yan Zhao; Qian Wang; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2021-06-29       Impact factor: 2.980

8.  Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.

Authors:  E T Koh; A Seow; B Ong; P Ratnagopal; H Tjia; H H Chng
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

9.  Investigations into Ro-specific antibody-associated congenital cardiac conduction defects.

Authors:  T Dörner; F Hiepe; B Göldner; E Apostoloff
Journal:  Clin Investig       Date:  1992-06

10.  Association of Anti-Ro/Sjögren's syndrome type A Antibodies and Complete Atrioventricular Block in an Adult With Sjögren's Syndrome.

Authors:  Weng Kin Tam; Hui Ching Hsu; Ming Hsiung Hsieh; Jong Shiuan Yeh; Weng Chio Tam
Journal:  Arch Rheumatol       Date:  2017-10-12       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.